Cost Effectiveness of Eplerenone for the Treatment of Systolic Heart Failure with Mild Symptoms in Alberta, Canada
Crossref DOI link: https://doi.org/10.1007/s40256-016-0177-0
Published Online: 2016-06-14
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thanh, Nguyen X.
Ezekowitz, Justin A.
Tran, Dat T.
Kaul, Padma
Funding for this research was provided by:
Pfizer Canada
License valid from 2016-06-14